MEI PHARMA INC (MEIPXXXX)
Institutional ownership reported to the SEC as of Q2 2023, across 19 quarters.
1
Reporting holders
$958
Reported value
0.0%
Held as options
-34
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| Boxer Capital, LLC | $958 | 145,654 | 0.04% | 19q | -95.0%-$18.2K |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2023 | 1 | $958 | 145,654 | 0 | 0 | 1 | 0.0% |
| Q1 2023 | 35 | $8.5M | 36,988,644 | 5 | 7 | 7 | 0.1% |
| Q4 2022 | 36 | $9.2M | 37,574,191 | 5 | 7 | 7 | 0.2% |
| Q3 2022 | 57 | $18.4M | 47,619,592 | 7 | 13 | 15 | 0.1% |
| Q2 2022 | 63 | $29.1M | 47,459,371 | 15 | 14 | 23 | 1.3% |
| Q1 2022 | 90 | $34.8M | 56,434,204 | 19 | 31 | 23 | 1.1% |
| Q4 2021 | 107 | $241.2M | 89,394,859 | 19 | 30 | 32 | 1.1% |
| Q3 2021 | 104 | $180.1M | 65,180,179 | 7 | 26 | 41 | 0.1% |
| Q2 2021 | 109 | $197.3M | 69,020,087 | 11 | 39 | 39 | 0.3% |
| Q1 2021 | 107 | $244.0M | 70,792,040 | 11 | 32 | 34 | 0.5% |
| Q4 2020 | 109 | $174.2M | 65,512,897 | 14 | 46 | 24 | 0.7% |
| Q3 2020 | 104 | $207.2M | 66,090,906 | 16 | 30 | 37 | 0.5% |
| Q2 2020 | 103 | $260.6M | 62,875,758 | 33 | 39 | 20 | 0.4% |
| Q1 2020 | 78 | $103.6M | 64,584,147 | 12 | 30 | 19 | 0.0% |
| Q4 2019 | 77 | $124.4M | 50,142,323 | 14 | 29 | 19 | 0.0% |
| Q3 2019 | 70 | $63.1M | 36,911,183 | 9 | 17 | 27 | 1.8% |
| Q2 2019 | 71 | $127.1M | 48,154,207 | 20 | 24 | 14 | 5.3% |
| Q1 2019 | 62 | $126.5M | 41,010,769 | 10 | 19 | 15 | 0.5% |
| Q4 2018 | 57 | $106.4M | 40,292,506 | 1 | 3 | 1 | 0.3% |